These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
124 related articles for article (PubMed ID: 2910699)
21. Pharmacokinetics of cefdinir and its transfer to dialysate in patients with chronic renal failure undergoing continuous ambulatory peritoneal dialysis. Tomino Y; Fukui M; Hamada C; Inoue S; Osada S Arzneimittelforschung; 1998 Aug; 48(8):862-7. PubMed ID: 9748717 [TBL] [Abstract][Full Text] [Related]
22. Residual renal function in children treated with continuous ambulatory peritoneal dialysis or automated peritoneal dialysis--a preliminary study. Roszkowska-Blaim M; Skrzypczyk P; Drozdz D; Pietrzyk JA Adv Perit Dial; 2009; 25():103-9. PubMed ID: 19886329 [TBL] [Abstract][Full Text] [Related]
23. [The effect of the number of peritonitis episodes on peritoneal membrane function]. Jovanović D; Nesić V; Dimitrijević Z Srp Arh Celok Lek; 1999; 127(1-2):28-31. PubMed ID: 10377837 [TBL] [Abstract][Full Text] [Related]
24. [Aluminum poisoning in dialysis patients--diagnosis and therapy]. Vogelsang U Schweiz Rundsch Med Prax; 1994 Jun; 83(24):738-56. PubMed ID: 8023059 [TBL] [Abstract][Full Text] [Related]
25. Impact of dialysis duration and glucose absorption on nutritional indices in stable continuous ambulatory peritoneal dialysis patients. Pajek J; Gucek A; Kveder R; Bucar-Pajek M; Kaplan-Pavlovcic S; Bren AF J Ren Nutr; 2008 Nov; 18(6):503-8. PubMed ID: 18940653 [TBL] [Abstract][Full Text] [Related]
26. Pharmacokinetics of intravenous ceftizoxime in patients on continuous ambulatory peritoneal dialysis. Johnson CA; Zimmerman SW; Bayer W; Craig WA Clin Nephrol; 1985 Mar; 23(3):120-4. PubMed ID: 3857136 [TBL] [Abstract][Full Text] [Related]
27. Aluminum toxicokinetics in peritoneal dialysis patients. Yue CS; Christie M; Lavergne V; Sikaneta T; Taskapan H; Mardini K; Tam P; Ting R; Ghannoum M Clin Toxicol (Phila); 2011 Aug; 49(7):659-63. PubMed ID: 21819285 [TBL] [Abstract][Full Text] [Related]
28. Role of aluminum hydroxide in raising serum aluminum levels in children undergoing continuous ambulatory peritoneal dialysis. Salusky IB; Coburn JW; Paunier L; Sherrard DJ; Fine RN J Pediatr; 1984 Nov; 105(5):717-20. PubMed ID: 6502300 [TBL] [Abstract][Full Text] [Related]
32. [Hyperaluminemia in chronic hemodialysis patients. Evaluation of the respective roles of dialysate aluminum and oral aluminum hydroxide]. Tahiri Y; Moriniere P; Jaudon MC; Dkhissi H; Rosa A; Fournier A Nephrologie; 1983; 4(3):129-33. PubMed ID: 6633778 [TBL] [Abstract][Full Text] [Related]
33. Bone mineral and aluminum concentrations in patients undergoing CAPD. Giangrande A; Costanini S; Ballanti P; Castiglioni A; Caligara F; Pisoni B; Giordano R; Vernillo I; Berni S; Bonucci E Adv Perit Dial; 1992; 8():351-5. PubMed ID: 1361821 [TBL] [Abstract][Full Text] [Related]
34. Use of magnesium hydroxide and low magnesium dialysate does not permit reduction of aluminum hydroxide during continuous ambulatory peritoneal dialysis. Jennings AE; Bodvarsson M; Galicka-Piskorska G; Diefendorf AS; Simon GM; Levey AS Am J Kidney Dis; 1986 Sep; 8(3):192-5. PubMed ID: 3752074 [TBL] [Abstract][Full Text] [Related]
35. Phosphate binders do not reduce bioavailability of oral cefuroxime-axetil in patients on peritoneal dialysis treatment. Brink HS; Huisman RM; Geerlings W; de Jong PE Adv Perit Dial; 1994; 10():179-82. PubMed ID: 7999822 [TBL] [Abstract][Full Text] [Related]
36. Bone aluminum deposition in maintenance dialysis patients treated with aluminium-free dialysate: role of aluminium hydroxide consumption. Heaf JG; Pødenphant J; Andersen JR Nephron; 1986; 42(3):210-6. PubMed ID: 3945361 [TBL] [Abstract][Full Text] [Related]
37. Relative roles of intestinal absorption and dialysis-fluid-related exposure in the accumulation of aluminium in haemodialysis patients. Mazzaferro S; Perruzza I; Costantini S; Pasquali M; Onorato L; Sardella D; Giordano R; Ciaralli L; Ballanti P; Bonucci E; Cinotti GA; Coen G Nephrol Dial Transplant; 1997 Dec; 12(12):2679-82. PubMed ID: 9430871 [TBL] [Abstract][Full Text] [Related]
38. Free choline and phospholipid-bound choline concentrations in serum and dialysate during peritoneal dialysis in children and adults. Ilcol YO; Dönmez O; Yavuz M; Dilek K; Yurtkuran M; Ulus IH Clin Biochem; 2002 Jun; 35(4):307-13. PubMed ID: 12135694 [TBL] [Abstract][Full Text] [Related]
39. Separation/preconcentration methods for the determination of aluminum in dialysate solution and scalp hair samples of kidney failure patients. Khan S; Kazi TG; Baig JA; Afridi HI; Kolachi NF Biol Trace Elem Res; 2011 Dec; 144(1-3):205-16. PubMed ID: 21573872 [TBL] [Abstract][Full Text] [Related]
40. Prospective evaluation of aluminum loading from formula in infants with uremia. Salusky IB; Coburn JW; Nelson P; Goodman WG J Pediatr; 1990 May; 116(5):726-9. PubMed ID: 2329421 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]